• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry.
 

Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry.

Options
  • Details
  • Files
BORIS DOI
10.48350/186271
Publisher DOI
10.1093/rheumatology/kead481
PubMed ID
37698987
Description
OBJECTIVES

To compare clinical characteristics, including the frequency of cutaneous, extramuscular manifestations, and malignancy, between adults with anti-synthetase syndrome (ASyS) and dermatomyositis (DM).

METHODS

Using data regarding adults from the MYONET registry, a cohort of DM patients with anti-Mi2/-TIF1ɣ/-NXP2/-SAE/-MDA5 autoantibodies, and a cohort of ASyS patients with anti-tRNA synthetase autoantibodies (anti-Jo1/-PL7/-PL12/-OJ/-EJ/-Zo/-KS) were identified. Patients with DM sine dermatitis or with discordant dual autoantibody specificities were excluded. Sub-cohorts of patients with ASyS with or without skin involvement were defined based on presence of DM-type rashes (heliotrope rash, Gottron's papules/sign, violaceous rash, shawl sign, V sign, erythroderma, and/or periorbital rash).

RESULTS

In total 1,054 patients were included (DM, n = 405; ASyS, n = 649). In ASyS cohort, 31% (n = 203) had DM-type skin involvement (ASyS-DMskin). A higher frequency of extramuscular manifestations, including Mechanic's hands, Raynaud's phenomenon, arthritis, interstitial lung disease, and cardiac involvement differentiated ASyS-DMskin from DM (all p< 0.001), whereas higher frequency of any of four DM-type rashes: heliotrope rash (n = 248, 61% vs n = 90, 44%), violaceous rash (n = 166, 41% vs n = 57, 9%), V sign (n = 124, 31% vs n = 28, 4%), and shawl sign (n = 133, 33% vs n = 18, 3%) differentiated DM from ASyS-DMskin (all p< 0.005). Cancer-associated myositis (CAM) was more frequent in DM (n = 67, 17%) compared with ASyS (n = 21, 3%) and ASyS-DMskin (n = 7, 3%) cohorts (both p< 0.001).

CONCLUSION

DM-type rashes are frequent in patients with ASyS; however, distinct clinical manifestations differentiate these patients from classical DM. Skin involvement in ASyS does not necessitate increased malignancy surveillance. These findings will inform future ASyS classification criteria and patient management.
Date of Publication
2024-08-01
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
Antisynthetase syndrome MYONET Raynaud’s phenomenon cutaneous dermatomyositis epidemiology extramuscular malignancy rashes skin
Language(s)
en
Contributor(s)
Hum, Ryan Malcolm
Lilleker, James B
Lamb, Janine A
Oldroyd, Alexander G S
Wang, Guochun
Wedderburn, Lucy R
Diederichsen, Louise P
Schmidt, Jens
Danieli, Maria Giovanna
Oakley, Paula
Griger, Zoltan
Phuong, Thuy Nguyen Thi
Kodishala, Chanakya
Mercado, Monica Vazquez-Del
Andersson, Helena
De Paepe, Boel
De Bleecker, Jan L
Maurer, Britta
Universitätsklinik für Rheumatologie und Immunologie - Fachbereich Rheumatologie
Universitätsklinik für Rheumatologie und Immunologie
McCann, Liza
Pipitone, Nicolo
McHugh, Neil
New, Robert Paul
Ollier, William E
Krogh, Niels Steen
Vencovsky, Jiri
Lundberg, Ingrid E
Chinoy, Hector
Additional Credits
Universitätsklinik für Rheumatologie und Immunologie - Fachbereich Rheumatologie
Series
Rheumatology
Publisher
Oxford University Press
ISSN
1462-0332
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 9f4e9a [ 5.02. 18:48]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo